Medifast, Inc. (MED) Misses Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.08 -0.17%
EPS Growth %: -195.2%
Financial Fact:
Basic earnings per share: 0.51
Today's EPS Names:
SICP, MNSB, CFFI, More
EPS Growth %: -195.2%
Financial Fact:
Basic earnings per share: 0.51
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q1 EPS of $0.29, $0.08 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $88.9 million versus the consensus estimate of $85.75 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- StoneX Reiterates Hold Rating on Meta Platforms Inc. (META) as Strategy Lacks Quantified Returns, Product Economics
- Nokia shares fall despite earnings beat on cash flow concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
